You are here: Industry Insights > MERS

News List

Celltrion says COVID-19 drug shows drop in viral load in animal testing expresspharma
June 02, 2020
Celltrion has research experience with other types of coronavirus conditions such as Middle East Respiratory Syndrome (MERS).
Outbreak alliance hands Johnson & Johnson, Oxford $18.7M for MERS work and more fiercepharma
September 28, 2018
J&J and Oxford University snagged $18.7 million for work on MERS, Lassa and Nipah vaccines.
First clinical MERS vaccine by Inovio and GeneOne shows promise fiercevaccines
July 23, 2018
Inovio and GeneOne Life Science’s MERS vaccine, which is receiving financial support from the International Vaccine Institute (IVI) and the Coalition for Epidemic Preparedness Innovations (CEPI), elicited high levels of antibodies and T-cell responses in
First clinical MERS vaccine by Inovio and GeneOne shows promise fiercevaccines
July 10, 2018
Inovio and GeneOne Life Science’s MERS vaccine, which is receiving financial support from the International Vaccine Institute (IVI) and the Coalition for Epidemic Preparedness Innovations (CEPI), elicited high levels of antibodies and T-cell responses in
Profectus, Emergent BioSolutions and PATH join forces in search for a Nipah vaccine fiercepharma
May 30, 2018
Outbreak-focused Coalition for Epidemic Preparedness Innovations (CEPI) has already shelled out three times to support research on MERS and Lassa fever vaccines.